NYLIM
CVET

New York Life Investment Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

New York Life Investment Management’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-319,958
Closed -$6.68M – 1227
2022
Q3 		$6.68M Buy
319,958
+7,336
+2% +$153K 0.08% 250
2022
Q2 		$6.49M Buy
+312,622
New +$5.56M 0.08% 266

Other funds holding CVET

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

New York Life Investment Management's CVET Position: Q4 2022 in Review

New York Life Investment Management sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 319,958 shares — an estimated $6.68M sold.

New York Life Investment Management first reported a position in CVET in Q2 2022 and held it in 2 quarters. The position peaked at $6.68M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • New York Life Investment Management reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • New York Life Investment Management sold 319,958 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $6.68M.
  • New York Life Investment Management first reported a position in Covetrus, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • New York Life Investment Management's Covetrus, Inc. Common Stock position peaked at $6.68M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on New York Life Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.